Gilead står fast vid hivsatsning – trots hotad finansiering

Gilead Sciences planerar fortfarande att leverera sitt hiv-läkemedel till låginkomstländer om det godkänns i USA, trots osäker finansiering efter Trumpadministr...

Quretech granted a European patent for a new type of antibiotic

The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.

ZEISS receives FDA clearance for INTRABEAM 700

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy.

Bolag tiodubblade läkemedelpris – döms till miljardböter

En brittisk appellationsdomstol har fastställt en bötessumma på 99 miljoner pund, motsvarande nästan 1,3 miljarder kronor, för ägarna av läkemedelsbolaget Advan...

AI detects tumor disease – via voice recording

A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...

Aqilion's licensing journey: From Merck partnership to new opportunities

Be extremely meticulous with your scientific data, but spend just as much time and effort on business development. That piece of advice comes from Aqilion's CEO...

Developing rapid diagnostics for sepsis – “Every hour counts”

Finding the right antibiotic in the right dose – with an ultra-fast analysis method. Gradientech's product solution is currently used in routine diagnostics at ...

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Jätteaffär inom cancerläkemedel – GSK betalar 100 miljarder

Brittiska GSK köper Bostonbaserade Nuvalent för 10,6 miljarder dollar, motsvarande nästan 100 miljarder kronor, i en affär som omfattar flera nya potentiella lä...

Första injicerbara cancerläkemedlet för hemmabruk får grönt ljus

Johnson & Johnson meddelar att deras storsäljande cancerläkemedel Darzalex (daratumumab) ser ut att bli den första injicerbara cancerbehandlingen i Europa som k...

Ukraine war fuels rise of totally resistent bacteria

War-torn Ukraine is not just suffering from hostile attacks from a foreign aggressor, but also from the threat of a totally resistant and contagious bacteria.

Eli Lilly requests re-examination of Alzheimer's drug recommendation

Eli Lilly has requested that the EMA re-examine its opinion on the company's Alzheimer's drug, Kisunla, the agency announced on Friday.

Mendus breddar klinisk prövning inom blodcancer

Immunterapibolaget Mendus inleder en klinisk prövning av sin ledande läkemedelskandidat vididencel inom kronisk myeloisk leukemi.

TFS Trial Form Support AB

Achieve Effortless, Standardized Automation with the new ZEISS Automation Interface

Simple interfaces for automated loading of CMMs.

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

A tiny animal with great importance

From the mythical Ganges River to the less sacred, but considerably cleaner waters in KI's aquariums in Solna. The little zebrafish has made an unconscious care...

Amrop Malmö AB

Han tar över TLV: ”Hedrad och förväntansfull”

Magnus Thyberg utses av regeringen till ny generaldirektör för Tandvårds- och läkemedelsförmånsverket.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

CSL Behring: Nya terapier kräver nya betalningsmodeller

DEBATT: NT-rådets beslut att inte rekommendera en genterapi för hemofili på grund av kostnad och osäker effektlängd belyser vikten av att terapier mot sällsynta...

Så används Nobelupptäckten i läkemedelsutveckling

Regulatoriska T-celler håller immunförsvaret i schack, en upptäckt som nu belönas med nobelpriset i fysiologi eller medicin 2025. Qiang Pan Hammarström berättar...